Rossi, Alexander J.
Khan, Tahsin M.
Saif, Areeba
Marron, Thomas U.
Hernandez, Jonathan M.
Article History
Received: 24 May 2021
Accepted: 25 May 2021
First Online: 11 June 2021
Disclosures
: T.U.M. has served as an advisor or data-safety boards for Regeneron, Boehringer Ingelheim, Atara, Genentech, AstraZeneca, Chimeric Therapeutics, Riboscience, Celldex, and Rockefeller University. He has research grants from Regeneron, Bristol-Myers Squibb, and Boehringer Ingelheim. The other authors declare they have no conflicts of interest and nothing to disclose.